论文部分内容阅读
我科将1986年8月至1988年11月住院的103例支气管哮喘患者,按就诊次序随机分为硝苯吡啶治疗组(以下简称治疗组)和氨茶碱治疗组(以下简称对照组),以双盲法观察疗效。服药方法:治疗组,按病情轻重,硝苯吡啶10mg口服每6~8小时一次。对照组,按病情轻重,氨茶碱0.1~0.2口服每6~8小时一次。两组均用药15日。服药期间每日6点、14点、22点观察患者的症状和体征变化。并根据血压、心率及心律变化随时作心电图。此外两组均未用其它平喘药,必要时吸氧、补液、使用抗生素等。
103 cases of bronchial asthma hospitalized in our hospital from August 1986 to November 1988 were randomly divided into nifedipine treatment group (hereinafter referred to as treatment group) and aminophylline treatment group (hereinafter referred to as control group) according to the order of treatment, Double-blind observation of efficacy. Medication: treatment group, according to severity, nifedipine 10mg orally every 6 to 8 hours. The control group, according to severity, aminophylline 0.1 ~ 0.2 oral once every 6 to 8 hours. Both groups were on the 15th. During the medication at 6 o’clock, 14 o’clock, 22 o’clock observation of patients with symptoms and signs of change. And according to blood pressure, heart rate and heart rate changes at any time for the ECG. In addition, the other two groups did not use other antiasthmatic drugs, if necessary, oxygen, fluid, the use of antibiotics.